Pathogenesis of retinopathy of prematurity (ROP): Up to date;ETIOPATOGENESI DELLA RETINOPATIA DELLA PREMATURITA (ROP): STATO DELL'ARTE

Pediatria Oggi Medica e Chirurgica

Volumn 16, Issue 2, 1996, Pages 57-63

  Romagnoli, C ^a   Gallini, F ^a   De Carolis, M P ^a   Maggio, L ^a   Papacci, P ^a   Rizzo, V ^a   Zecca, E ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

prematurity; retinopathy of prematurity

Indexed keywords

OXYGEN;

HUMAN; INCIDENCE; OXYGEN THERAPY; PREMATURITY; RETROLENTAL FIBROPLASIA; REVIEW; RISK FACTOR;

EID: 0029886671     PISSN: 0391898X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (76)

1. Ackermann B., Sherwonit E., Williams J.: Reduced incidental light exposure: effect on development of retinopathy of prematurity in low birth weight infants. Pediatrics, 83: 958-962, 1989.
2. Arroe M., Peirsen B.: Retinopathy of prematurity in a Danish neonatal intensive care unit, 1985-1991. Acta Ophthalmol., 210 (suppl.): 37-40, 1993.
3. Ashton N., Ward B., Serpell G.: Effect of oxygen on developing retinal vessels with particular reference to the problem of retrolental fibroplasia. Br. J. Ophthalmol., 38: 397-432, 1954.
4. Asztalos E.V., Ohlsson A., Shennan A.T. et al.: Is desamethasone treatment (DxT) a risk factor for retinopathy of prematurity (ROP)? Report of a case-control study. Pediatr. Res., 29: 201 (Abs), 1991.
5. Avery G.B., Glass P.: Light and retinopathy of prematurity: what is prudent for 1986? Pediatrics, 78: 519-520, 1986.
6. Avery G. B., Glass P.: Retinopathy of prematurity: what causes it? Clin. Perinatol., 15: 917-928, 1988.
7. Bancalari E., Flynn J., Goldberg R.N. et al.: Influence of transcutaneous oxygen monitoring on the incidence of retinopathy of prematurity. Pediatrics, 79: 663-669, 1987.
8. Batton D.G., Roberts C., Trese M. et al.: Severe retinopathy of prematurity and steroid exposure. Pediatrics, 90: 534-536, 1992.
9. 2 and retrolental fibroplasia. Pediatr. Res., 15: 649 (Abs), 1981.
10. Bech N., Fledelius H.C., Rosenberg T.: Retinopathy of prematurity 1974-91. An analysis of the Danish register for the visual impaired. Acta Ophthalmol., 210 (suppl.): 12-15, 1993.
11. Brown D.R., Milley J.R., Ripep V.J. et al.: Retinopathy of prematurity. Risk factors in a five-year cohort of critically ill premature neonates. Am. J. Dis. Child., 141: 154-160, 1987.
12. Brown D.R., Biglan A.W., Stretavsky M.M.A.: Retinopathy of prematurity: the relationship with intraventricular haemorrhage and bronchopulmonary dysplasia. J. Pediatr. Ophthalmol. & Strab., 27: 268-271, 1990.
13. Bruckner H.L.: Retrolental fibroplasia associated with intrauterine anoxia? Arch. Ophthalmol., 80: 504-505, 1968.
14. Campbell K.: Intensive oxygen therapy as a possible cause of retrolental fibroplasia: a clinical approach. Med. J. Aust., II: 48-50, 1951.
15. Clark C., Gibbs J.A., Maniello R. et al.: Blood transfusion: a possible risk factor in retrolental fibroplasia. Acta Paediatr. Scand., 70: 535-539, 1981.
16. Console V., Raimondi A., Marsili M.T. et al.: Indagine multicentrica retrospettiva sulla ROP acuta in neonati con peso ≤ 1500 grammi nel biennio 1985-1986. Neonatologica, 3: 94-100, 1989.
17. Davies P.A.: Retinopathy of prematurity. Dev. Med. Child. Neur., 32: 377-378, 1990.
18. Editorials: Oxygen restriction and retinopathy of prematurity. Lancet. 339: 961-963, 1992.
19. Ehrenkranz R.A.: Steroids, chronic lung disease, and retinopathy of prematurity. Pediatrics, 90: 646-647, 1992.
20. Fielder A.R., Shaw D.E., Robinson J., Ng Y.K.: Natural history of retinopathy of prematurity: a prospective study. Eye, 6: 233-242, 1992.
21. Fielder A.R., Levene M.I.: Screening for retinopathy of prematurity. Arch. Dis. Child., 67: 860-867, 1992.
22. Fledelius H.C.: Retinopathy of prematurity. Clinical findings in a Danish county 1982-1987. Acta Ophthalmol., 68: 209-213, 1990.
23. Fledelius H.C.: Retinopathy of prematurity in Frederiksborg county 1988-1990. A prospective investigation, an update. Acta Ophthalmol., 210 (suppl.): 59-62, 1993.
24. Fledelius H.C., Greisen G.: Very pre-term birth and visual impairment. Acta Ophthalmol., 210 (suppl.): 63-65, 1993.
25. Flynn J.T., O'Grady G.E., Herrera J. et al.: Retrolental fibroplasia: clinical and observations. Arch. Ophthalmol., 95: 217-223, 1977.
26. Flynn J.T., Bancalari E., Snyder E.S., Goldberg R.N., Feuer W., Cassady J., Schiffman J., Feldman H.I., Bachynski B., Buckeley E., Roberts J., Gillings D.: A cohort study of transcutaneous oxygen tension and the incidence and severity of retinopathy of prematurity. N. Engl. J. Med., 326: 1050-1054, 1992.
27. Flower R.W., McLeod D.S., Lutty G.A. et al.: Postnatal retinal vascular development of the puppy. Invest. Ophthalmol. Vis. Sci., 26: 957-968, 1984
28. Gaton D.D., Gold J., Axer-Siegel R. et al.: Evaluation of bilirubin as possible protective factor in the prevention of retinopathy of prematurity. Br. J. Ophthalmol., 75: 532-534, 1991.
29. Gibson D.L., Sheps S.B., Schechter M.T. et al.: Retinopathy of prematurity: a new epidemic? Pediatrics, 83: 486-492, 1989.
30. Glass P., Avery G.B., Subramanian K.N. et al.: Effect of bright light in the hospital nursery on the incidence of retinopathy of prematurity. N. Engl. J. Med., 313: 401-404, 1985.
31. Glass P.: Light and the developing retina. Doc. Ophthalmol., 74: 195-203, 1990.
32. Gong A.K., Van Heuven W.A.J., Berlanga M, et al.: Severe retinopathy in convalescent preterm infants with mild or regressing retinopathy of prematurity. Pediatrics, 83: 422-425, 1989.
33. Greisen G.: ROP in three follow-up studies from Rigshospitalet during the period 1976-1987. Acta Ophthalmol., 210 (suppl.): 30-33, 1993.
34. Harris A.P., Sendak M.J., Donham R.T.: Changes in arterial oxygen saturation immediately after birth in the human neonate. J. Pediatr., 109: 117-119, 1986.
35. Hittner H.M., Kretzer F.L.: Efficacy of vitamin E in retinopathy of prematurity. In: McPherson A.R., Hittner H.M., Kretzer F.L. (eds.): Retinopathy of prematurity. Philadelphia, BC Decker, 1986, pagg. 89-103.
36. Holmstrom G., el Azazi M., Jacobson L., Lennerstrand G.: A population based, prospective study of the development of ROP in prematurely born children in the Stockholm area of Sweden. Br. J. Ophthalmol., 77: 417-423, 1993.
37. Kretzer F.L., Hittner H.M.: Retinopathy of prematurity: clinical implications of retinal development. Arch. Dis. Child., 63: 1151-1167, 1988.
38. Jacobsen L., Stenstrom I.: Visually impairing ROP in children born in Sweden 1975-89 Acta Ophthalmol., 210 (suppl.): 16-19, 1993.
39. James L.S., Lanman J.T.: History of oxygen therapy and retrolental fibroplasia. Pediatrics, 57 (suppl.): 591-642, 1976.
40. John E., Todd D.A.: Patent ductus arteriosus and retinopathy of prematurity in infants below 27 weeks gestation. Aust. Paediatr. J., 24: 171-173, 1988.
41. Johnson L.H., Schaffer D.D., Blesa M.I. et al.: Factors predisposing to RLF: complications of pregnancy. Pediatr. Res., 12: 527 (Abs). 1978.
42. Johnson L.H., Quinn G.E., Abbassi E. et al.: Effect of sustained pharmacologic vitamin E levels on incidence and severity of retinopathy of prematurity: a controlled clinical trial. J. Pediatr., 114: 827-838, 1989.
43. Johnson L.H., Quinn G.E., Abbassi S., Bowen F.W.: Retinopathy of prematurity: prevalence and treatment over a 20 year period at Pennsylvania hospital. Doc. Ophthalmol., 74: 213-222, 1990.
44. Lakatos L., Hatuani I., Orozlan G. et al.: D-penicillamine in the prevention of retrolental fibroplasia. Acta Paediatr. Hung., 23: 327-335, 1982.
45. Landers M.B., Toth C.A., Sample H.C. et al.: Treatment of retinopathy of prematurity with argon laser photocoagulation. Arch. Ophthalmol., 110: 44-47, 1992.
46. Lanum J.: The damaging effects of light on the retina: empirical findings, theoretical and practical implications. Surv. Ophthalmol., 22: 221-249, 1978.
47. Lappi M.: Retinopathy of prematurity in southern Finland. Acta Ophthalmol., 210 (suppl.): 56-58, 1993.
48. Lindemann R., Blystad W., Egge K.: Retrolental fibroplasia in premature infants with patent ductus arteriosus treated with indomethacin. Eur. J. Pediatr., 138: 56-58, 1982.
49. Lucey J.F., Dangman B.: A reexamination of the role of oxygen in retrolental fibroplasia. Pediatrics, 73: 82-96, 1984.
50. Maly E.: Frequency and natural history of retinopathy of prematurity (ROP). A prospective study in Swedish city 1986-1990. Acta Ophthalmol., 210 (suppl.): 52-55, 1993.
51. Muller D.P.R.: Vitamin E therapy in retinopathy of prematurity. Eye, 6: 221-225, 1992.
52. Multicenter trial of cryotherapy for retinopathy of prematurity: Preliminary results. Pediatrics, 81: 697-706, 1988.
53. Multicenter trial of cryotherapy for retinopathy of prematurity: One year outcome - Structure and function. Arch. Ophthalmol., 108: 1408-1416, 1990.
54. Ng Y.K., Fielder A.R., Levene M.I. et al.: Are severe acute retinopathy of prematurity and severe periventricular leucomalacia both ischaemic insults? Br. J. Ophthalmol., 73: 111-1 14, 1989.
55. Owens W.C., Owens E.V.: Retrolental fibroplasia in premature infants. II. Studies on the prophylaxis of the disease: the use of alpha-tocopheryl acetate. Am. J. Ophthalmol., 32: 1631-1637, 1949.
56. Palmer E.A., Flynn J.T., Hardy R.J. et al.: Incidence and early course of retinopathy of prematurity. Ophthalmology, 98: 1628-1640, 1991.
57. Patz A., Hoeck L.E., De La Cruz E.: Studies on the effect of oxygen administration in retrolental fibroplasia. I. Nursing observation. Am. J. Ophthalmol., 35: 1248-1252, 1952.
58. Phelps D.L.: Retinopathy of prematurity: An estimate of vision loss in the United States - 1979. Pediatrics, 67: 924-926, 1981.
59. Phelps D.L., Rosenbaum A.L., Senberg S.J. et al.: Safety of intravascular tocopherol in a random double-blind trial in premature infants. Pediatr. Res., 18: 158, 1984.
60. Porat R.: Care of the infant with retinopathy of prematurity. Clin. Perinatal., 11: 123-151, 1984.
61. Prendiville A., Schulenburg W.: Clinical factors associated with retinopathy of prematurity. Arch. Dis. Child., 63: 522-527, 1988.
62. Repka X.M., Hudak M.L., Parsa C.F. et al.: Calf lung surfactant extract prophylaxis and retinopathy of prematurity. Ophthalmol., 99: 531-536, 1992.
63. Ricci B.: Oxygen-induced retinopathy in the rat model. Doc. Ophthalmol., 74: 171-177, 1990.
64. Robinson J., Fielder A.R.: Light and the immature visual system. Eye, 6: 166-172, 1992.
65. Saito Y., Omoto T., Cho Y., Hatsukawa Y., Fujimura M., Takeuchi T.: The progression of retinopathy of prematurity and fluctuations in blood gas tension. Greafe's Arch. Clin. Exp. Ophthalmol., 231: 151-156, 1993.
66. Shohat M., Reisner S.H., Krikler R. et al.: Retinopathy of prematurity: incidence and risk factors. Pediatrics, 72: 159-163, 1986.
67. Sobel D.B., Philip A.G.S.: Prolonged dexamethasone therapy reduces incidence of cryotherapy for retinopathy of prematurity in infants of less than 1 kilogram birth weight with bronchopulmonary dysplasia. Pediatrics, 90: 529-533, 1992.
68. Stannard K.P., Mushin A.S., Gamsu H.R.: Screening for retinopathy of prematurity in a regional neonatal intensive care unit. Eye, 3: 371-378, 1989.
69. 2 consumption in rhesus monkeys in light and dark. Exp. Eye Res., 37: 251-256, 1983.
70. Stiris T., Hansen T.W.R., Odden J.P. et al.: Effect of light and hyperoxia on ocular blood flow in the newborn piglet. Biol. Neonate, 55: 191-196, 1989.
71. Stiris T., Hall C., Bratild D.: Retinal, choroidal and total ocular blood flow response to hypercarbia during spontaneous brething and mechanical ventilation. Biol. Neonate, 59: 86-92, 1991.
72. Sullivan J.L.: Retinopathy of prematurity and iron: a modification of the oxygen hypothesis. Pediatrics, 78: 1171-1172, 1986.
73. Terry T.L.: Extreme prematurity and fibroblastic overgrowth of persistent vascular heath behind each crystalline lens. Am. J. Ophthalmol., 25: 203-204, 1942.
74. Terry T.L.: Retrolental fibroplasia. J. Pediatr., 29: 770-773, 1946.
75. Weakley D.R., Spencer R.: Current concept in retinopathy of prematurity. Early Human Development, 30: 121-138, 1990.
76. Zuckerman R., Weiter J.J.: Oxygen transport in the bullfrog. Exp. Eye Res., 30: 117-127, 1980.